SYMATESE GROUP Information

For more than 30 years SYMATESE GROUP has designed, produced and marketed medical devices according to its know-how particularly in the field of biopolymers, silicone transformation and plastic injection. Our core subsidiaries SYMATESE, SYMATESE DEVICE, SYMATESE AESTHETICS design and produce our medical devices according to international quality and regulatory requirements to allow for a worldwide market access. 280 collaborators participate in these missions including its commercial branches in Brazil and China respectively with SYMATESE LATAM and SYMATESE SHANGHAI. Our manufacturing plant SYMATESE AESTHETICS ltd produces the newly designed breast implants. With its BtoB activity SYMATESE GROUP provides its experience and expertise for the design and manufacturing of medical devices to medical, pharmaceutical and cosmetic companies. The renewed confidence of its leading partners in their respective domains like cardiovascular, orthopedics, ophthalmology, aesthetic medicine and plastic surgery, associated with the performances of its products, confirms SYMATESE GROUP recognition for the quality of its products, its innovation capacity, competencies and employee’s expertise. To prepare the future, SYMATESE GROUP has joined its skills and existing knowledge, to provide practitioners with products of the highest quality typically in the medical and surgical aesthetics market with its new hyaluronic acid wrinkle dermal fillers range and its breast implants for which we expect CE marking in the near future.